FRGT (FRGT) Stock Price & Analysis
FRGT (FRGT) rose 0.00% to USD 3.01 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
FRGT last closed at USD 3.01; the session ranged USD 3–3.15 on volume of 13,292 shares. Market capitalization is —, with a 52-week range of USD 2.52–51.5 (NCM). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 3.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.01 |
| Open | USD 3.01 |
| Day Range | USD 3 – 3.15 |
| 52-Week Range | USD 2.52 – 51.5 |
| Volume | 13,292 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (FRGT)
Nexqual's technical model rates FRGT "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.25 (neutral) |
| vs SMA50 | Below (USD 3.92) |
| MACD | -0.19 (negative) |
From FRGT's Latest SEC 10-K Filing (filed 2025-04-14)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| TGL | Treasure Global Inc. | USD 3.06 | ▼ 6.42% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| FOXOD | FOXO Technologies Inc. | USD 0.03 | ▼ 6.33% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.